D
Dr David Blacker

How does this work?
About

David Blacker is a neurologist and stroke physician at Sir Charles Gairdner Hospital, Clinical Professor of Neurology at the University of Western Australia and Medical Director of the Perron Institute of Neurological and Translational Science. He graduated MB BS from the University of Western Australia in 1991, and FRACP in 2002, specializing in Neurology. He completed fellowships in Advanced Clinical Neurology and Cerebrovasular Medicine at the Mayo Clinic, Rochester MN, USA, returning to Australia to commence full time neurology practice with a subspecialty in Stroke Medicine. He established the Acute Stroke service at Sir Charles Gairdner Hospital, which has grown into one of Australia’s busiest interventional stroke services with more than 1000 acute stroke calls per year , providing approximately 300 acute interventions, covering the largest geographic territory ( Western Australia ) of any stroke service in the world. He has participated in clinical stroke trials for almost 20 years, and has worked with the experimental stroke group at the Perron Institute on neuroprotection. He is a founding clinical adviser to Argenica Therapeutics, a biotech company developing a polyarginine peptide neuroprective drug, which at preclinical stages appears more effective than NA—1, the current world leading neuroprotective agent developed in Canada. In the last 2 years he has reduced clinical work to focus on research, and to address his personal fight with Parkinson’s disease. He has publicized this with clinical papers in Practical Neurology (Nov 2020) and the Internal Medicine Journal ( early 2021) along with interviews for the World Federation of Neurology for World Brain Day (July 2020). He has developed a great interest in exercise for brain health, and had designed a program of non contact boxing for Parkinson’s Disease, the Feasibility of Instituting Graduated High intensity Training (FIGHT- PD) in collaboration with a former national boxing champion and exercise scientists. Currently before ethics, this should commence in early 2021, as the first of a series of exercise based studied for PD.

Ask me about
Stroke intervention and neuroptotection
Work experience

Nov 2014 - Present

Perron Institute

Medical Director

Medical Director Clinician Clinical researcher

Aug 2003 - Present

Sir Charles Gairdner Hospital

Neurologist

Clinical neurology and stroke services

Education

2002 - 2003

Mayo Clinic

Cerebrovascular Diseases Fellow, Stroke medicibe

Clinical stroke fellowship

2001 - 2002

Mayo Clinic

Advanced Clinical Neurology Fellowship, Clinical Neurology

Clinical Neurology felliwship

1996 - 2002

Royal Australasian College of Physicians

FRACP, Specialty medical training

Neurology specialty training

1986 - 1991

University of Western Australia

MB BS, Medical

Undergraduate medical achool

Board Certified

Talk to David

@ Copyright 2020 OfficeHours Technologies Co.